Join us for an in-depth session on how we are revolutionizing cancer genomics through automation and comprehensive analysis. Our session will highlight the latest advancements in utilizing VarSeq to adhere to AMP guidelines for cancer variant analysis and clinical reporting. Discover how our automation capabilities streamline the interpretation of complex genomic signatures and allow for more efficient and scalable laboratory operations. We will be showcasing updates to CancerKB, which offers report-ready interpretations with multi-biomarker insights, tumor-specific therapies, and clinically significant results. Additionally, learn about our innovative approaches to methylation analysis, further enhancing precision in cancer diagnostics. This session is a must-attend for those looking to stay at the forefront of molecular oncology, leveraging cutting-edge tools that transform genomic data into actionable clinical insights.
